Elisabet Svenungsson is Senior Consultant and Professor of Rheumatology at the Karolinska University Hospital, Karolinska Institute, in Stockholm, Sweden. She completed her medical education at the Karolinska Institute, and is a specialist in internal medicine and rheumatology. She has been Head of the Inpatient Rheumatology Ward at the Karolinska University Hospital for many years.
Professor Svenungsson’s main clinical expertise is in systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), and cardiovascular comorbidity associated with systemic autoimmune diseases. Her research is based on clinical studies of the systemic autoimmune diseases, mainly SLE, APS, and systemic sclerosis. The main focus of these studies has been to understand why patients with autoimmune diseases are affected with premature cardiovascular disease (CVD); she has taken part in genetic studies of SLE and demonstrated the importance of genetic susceptibility to SLE-related CVD. Professor Svenungsson’s ongoing research focuses on CVD, autoantibodies, and genetics, as well as on neurological and renal manifestations and quality of life issues. A more recent general research interest is in the pathogenesis, subphenotypes, and diagnostic entities of systemic autoimmunity.
Professor Svenungsson is Principal Investigator of the Karolinska SLE cohort, which was set up in 1995 and now comprises 600–700 SLE patients and matched population controls. She previously chaired the cardiovascular study group and currently chairs the study group for a national SLE registry within the Swedish Society for Rheumatology. Professor Svenungsson is also President-elect of the board of SLEuro (the European Lupus Society).
EM-33039 - Date of preparation: May 2020